Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Anna Bosch Vilaseca, M.D.

Concepts (15)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Hodgkin Disease1202114170.110 Why?
Hematopoietic Stem Cell Transplantation2202154690.110 Why?
Graft vs Host Disease1202029570.080 Why?
Thiotepa12020660.050 Why?
Busulfan120202600.040 Why?
Vidarabine120203410.040 Why?
Tacrolimus120207250.040 Why?
Cyclophosphamide1202122520.030 Why?
Transplantation Conditioning1202015950.030 Why?
Transplantation, Homologous1202147940.030 Why?
Sirolimus1202015680.030 Why?
Feasibility Studies1202051440.020 Why?
Neoplasm Recurrence, Local1202193050.010 Why?
Retrospective Studies12020787580.010 Why?
Humans220217527410.000 Why?
Bosch Vilaseca's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (15)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.